Nasus Pharma | 6.47 +0.57 +9.66% | ||
| NSRX | |||
| 高 6.47 | 开 6.47 | 量 100股 | 总市值 7608.00万 |
| 低 6.47 | 换 0.00% | 额 647.00 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Nasus Pharma(NSRX)
02-13 21:55
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-26-006565 Act: 34 Size: 43 KB 网页链接
Nasus Pharma(NSRX)
02-12 19:06
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-26-006265 Act: 34 Size: 764 KB 网页链接
Nasus Pharma(NSRX)
01-30 05:25
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-26-004233 Act: 34 Size: 241 KB 网页链接
Nasus Pharma(NSRX)
01-20 21:25
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-26-002755 Act: 34 Size: 20 MB 网页链接
Nasus Pharma(NSRX)
2025-12-29 21:05
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-25-029210 Act: 34 Size: 4 MB 网页链接
Nasus Pharma(NSRX)
2025-12-22 21:25
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-25-028664 Act: 34 Size: 46 KB 网页链接
Nasus Pharma(NSRX)
2025-11-20 21:35
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-25-024400 Act: 34 Size: 48 KB 网页链接
Nasus Pharma(NSRX)
2025-11-18 21:25
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-25-023992 Act: 34 Size: 38 KB 网页链接
Nasus Pharma(NSRX)
2025-11-13 22:35
$Nasus Pharma(NSRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001493152-25-022144 Act: 34 Size: 20 KB 网页链接
Nasus Pharma(NSRX)
2025-11-13 05:16
$Nasus Pharma(NSRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001493152-25-021898 Act: 34 Size: 6 KB 网页链接
Nasus Pharma(NSRX)
2025-11-11 06:15
$Nasus Pharma(NSRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001493152-25-021552 Act: 34 Size: 6 KB 网页链接
Nasus Pharma(NSRX)
2025-11-03 21:05
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-25-020540 Act: 34 Size: 11 MB 网页链接
Nasus Pharma(NSRX)
2025-10-08 21:15
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-25-017378 Act: 34 Size: 39 KB 网页链接
Nasus Pharma(NSRX)
2025-10-01 04:15
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-25-016290 Act: 34 Size: 21 KB 网页链接
Nasus Pharma(NSRX)
2025-09-05 20:05
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-25-012675 Act: 34 Size: 16 KB 网页链接
Nasus Pharma(NSRX)
2025-08-21 05:05
$Nasus Pharma(NSRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001178913-25-003007 Act: 34 Size: 6 KB 网页链接
Nasus Pharma(NSRX)
2025-08-15 04:25
$Nasus Pharma(NSRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-25-011984 Act: 34 Size: 44 KB 网页链接
Nasus Pharma(NSRX)
2025-08-15 01:15
$Nasus Pharma(NSRX)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001641172-25-023826 Act: 33 Size: 7 MB 网页链接
Nasus Pharma(NSRX)
2025-08-13 18:15
$Nasus Pharma(NSRX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002578 Act: 33 Size: 1 KB 网页链接
Nasus Pharma(NSRX)
2025-08-13 04:45
$Nasus Pharma(NSRX)$ CERT Certification by an exchange approving securities for listing Accession Number: 0001143313-25-000055 Act: 34 Size: 411 KB 网页链接